Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
Clinical trial NCT00305019 · TERMINATED
Trial details
- NCT number
- NCT00305019
- Sponsor
- Bukwang Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.